Gosset Ownership
Private
Therapeutic Areas
Stage
Preclinical
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
AndroScience General Information
AndroScience leverages expertise in natural product chemistry to discover and develop small molecule drugs targeting the androgen activation pathway. The company’s pipeline addresses dermatological, urological, and oncological conditions linked to androgen signaling. They provide services supporting IND/NDA studies and clinical trials.
Contact Information
Primary Industry
Biotech
Corporate Office
San Diego, California
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
AndroScience Funding
No funding data available
To view AndroScience's complete valuation and funding history, request access »